Here, we present data demonstrating that while loss of the ISG CH25H and overactive IFN1 signaling promote TNBC progression to lung metastasis, reserpine is able to suppress TEV-induced cancer progression by downregulation of NUPR1 in TEV recipient cells and decrease NUPR1 in TEVs released by reserpine treated cancer cells. This evidence concerns the gene CH25H and cancer.